Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study

Author(s):
Noordman, B.J.; Spaander, M.C.W.; Valkema, R.; Wijnhoven, B.P.L.; Henegouwen, M.I.V.; Shapiro, J.; Biermann, K.; Gaast, A. van der; Hillegersberg, R. van; Hulshof, M.C.C.M.; Krishnadath, K.K.; Lagarde, S.M.; Nieuwenhuijzen, G.A.P.; Oostenbrug, L.E.; Siersema, P.D.; Schoon, E.J.; Sosef, M.N.; Steyerberg, E.W. (0000-0002-7787-0122); Lanschot, J.J.B. van; SANO study grp
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-07-31
Language
English
Is part of
The Lancet Oncology (2018), Vol. 19, no. 7, p. 965-974
hdl
1887/95763
doi
10.1016/S1470-2045(18)30201-8